Molecular cytogenetics encompasses the combination of molecular biology and cytogenetics. Molecular cytogenetics includes all the aspects of chromosome biology with a wide range of applications in disease diagnosis and chromosomal abnormalities. It enables to differentiate normal and cancer causing cells. In molecular cytogenetics, techniques such as fluorescence in situ hybridization (FISH) are conducted wherein DNA probes are labeled with different colored fluorescent tags to visualize the whole genome or the most specific regions of the genome. Molecular cytogenetics helps to study the structural and functional organization of chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities in medicinal and cancer-related genetics. The high prevalence of cancer and increasing application of molecular biology in the detection of inherited susceptibilities associated with cancer development is expected to boost the global molecular cytogenetics market growth.

Market Dynamics

To add advanced PSS hardware, software, columns, and reference materials to the product portfolio which will enhance the offerings and ensure delivery of the broad spectrum of LC equipment, GPC/SEC analytics, the key market players are focusing on adoption of growth strategies such as acquisition which is attributed to the growth of global molecular cytogenetics market. For instance, in August 2022, Agilent Technologies Inc., provider of instruments, software, services, etc., announced it has acquired Polymer Standards Service GmbH (PSS) a provider of solutions in the field of polymer characterization. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules.

Key features of the study:

• This report provides an in-depth analysis of the global molecular cytogenetics market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

• It profiles key players in the global molecular cytogenetics market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global molecular cytogenetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular cytogenetics market

Detailed Segmentation:

• Global Molecular Cytogenetics Market, By Product Type:
  • Instruments
  • Consumables
  • Software and Services
• Global Molecular Cytogenetics Market, By Technology:
  • FISH
  • aCGH
• Global Molecular Cytogenetics Market, By Application:
  • Genetic Disorders
  • Cancer
  • Personalized Medicine
  • Others
• Global Molecular Cytogenetics Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Abbott Laboratories*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.,
  • Applied Spectral Imaging, Inc.
  • BI Biological Industries
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific Inc.
  • CytoTest Inc.
  • Cytognomix Inc.
  • Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Bionano Genomics, Inc.
  • Precipio, Inc.
  • Leica Biosystems

 “*” marked represents similar segmentation in other categories in the respective section.